+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

GW Pharmaceuticals Ltd - Strategic SWOT Analysis Review

GW Pharmaceuticals Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Summarization of the company’s business strategy.
  • SWOT analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.

Highlights

GW Pharmaceuticals Plc (GW Pharmaceuticals), a subsidiary of Jazz Pharmaceuticals, is a biopharmaceutical company that discovers, develops and commercializes novel therapeutics from its proprietary plant-derived cannabinoid product platform. The company offers Sativex for the treatment of spasticity due to multiple sclerosis and Epidiolex for the treatment of seizures associated with Lennox-Gastaut syndrome or Dravet syndrome. It sells and distributes the product through strategic collaborations with other pharmaceutical companies. The company has subsidiaries in Australia, the US, England and Wales, and Guernsey. GW Pharmaceuticals is headquartered in Cambridge, England, the UK.

Reasons to Buy

  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with a detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.

Table of Contents

Section 1 - About the Company
  • GW Pharmaceuticals Ltd - Key Facts
  • GW Pharmaceuticals Ltd - Key Employees
  • GW Pharmaceuticals Ltd - Major Products and Services
  • GW Pharmaceuticals Ltd - History
  • GW Pharmaceuticals Ltd - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • GW Pharmaceuticals Ltd - Business Description
  • GW Pharmaceuticals Ltd - SWOT Analysis
  • SWOT Analysis - Overview
  • GW Pharmaceuticals Ltd - Strengths
  • GW Pharmaceuticals Ltd - Weaknesses
  • GW Pharmaceuticals Ltd - Opportunities
  • GW Pharmaceuticals Ltd - Threats
  • GW Pharmaceuticals Ltd - Key Competitors
Section 3 - Company’s Lifesciences Financial Deals and Alliances
  • GW Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
  • GW Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
  • GW Pharmaceuticals Ltd, Recent Deals Summary
Section 4 - Appendix
  • Methodology
  • About the Publisher
  • Contact the Publisher
  • Disclaimer
List of Tables
  • GW Pharmaceuticals Ltd, Key Facts
  • GW Pharmaceuticals Ltd, Key Employees
  • GW Pharmaceuticals Ltd, Major Products and Services
  • GW Pharmaceuticals Ltd, History
  • GW Pharmaceuticals Ltd, Other Locations
  • GW Pharmaceuticals Ltd, Subsidiaries
  • GW Pharmaceuticals Ltd, Key Competitors
  • GW Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
  • GW Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
  • GW Pharmaceuticals Ltd, Recent Deals Summary
List of Figures
  • GW Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
  • GW Pharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2018 to YTD 2024

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Takeda Pharmaceutical Co Ltd
  • Napp Pharmaceuticals Ltd
  • Zogenix Inc
  • Marinus Pharmaceuticals Inc
  • Immupharma Plc
  • Zynerba Pharmaceuticals Inc
  • Evotec SE
  • Oxford BioMedica Plc
  • Ovid Therapeutics Inc
  • Zogenix Inc
  • Marinus Pharmaceuticals Inc
  • Immupharma Plc
  • Oxford BioMedica Plc
  • Ovid Therapeutics Inc
  • Evotec SE
  • Takeda Pharmaceutical Co Ltd
  • Napp Pharmaceuticals Ltd
  • Zynerba Pharmaceuticals Inc